New Multicolor Electron Microscopy Technique Uses Standard Dyes to Achieve Nanometer Resolution

A Single Electron Beam Now Reveals Both Cellular Architecture and Protein Identity

For decades, biologists have faced a fundamental trade-off in microscopy: they could either see the fine structural details of cells using electron microscopy, or they could identify specific proteins using fluorescent tags in light microscopy—but rarely both at once. A new technique developed at Harvard University now breaks this barrier, allowing researchers to simultaneously capture high-resolution structural images and multicolor molecular labels using standard fluorescent dyes.

The method, called multicolor electron microscopy, achieves nanometer resolution—approximately ten times better than traditional light microscopy—by harnessing cathodoluminescence, a phenomenon where an electron beam excites fluorophores to emit visible light. Researchers Debsankar Saha Roy and Maxim Prigozhin from Harvard University will present their findings at the 70th Biophysical Society Annual Meeting in February 2026, marking a significant advance in bioimaging capabilities.

[IMAGE: Side-by-side comparison of a standard fluorescence microscopy image showing blurry puncta versus a multicolor electron microscopy image revealing sharp cellular structures with colored molecular labels in the same region.]

Traditional fluorescence microscopy, while excellent for identifying specific molecules, hits a resolution ceiling of approximately 250-300 nanometers. This limitation means individual proteins remain blurred, and the structural context of where these molecules reside within the cell is lost. Electron microscopy, on the other hand, can reveal atomic-scale details of cellular architecture—mitochondria, nuclear membranes, and cytoskeletal networks with stunning clarity—but cannot easily distinguish which proteins are present.

The Harvard team has now bridged this gap. By using a single electron beam to simultaneously generate a structural image and excite fluorescent probes, the technique produces what the researchers describe as a composite view: a high-resolution black-and-white structural map overlaid with colorful dots representing tagged proteins.

"The beauty of this approach is that you don't have to choose between structure and molecular identity anymore," said Roy, the study's lead author. "You get both in one experiment, at resolutions that were previously impossible with light alone."

Standard Fluorescent Dyes Work Under Electron Beam—A Discovery That Changes the Game

Perhaps the most surprising finding from the Harvard team is that commonly used fluorescent dyes—the same ones found in virtually every cell biology laboratory—emit visible light when excited by electrons. This phenomenon had not been systematically characterized before, and its discovery carries profound implications for the field.

Decades of well-characterized probes and labeling protocols are immediately compatible with the new technique. Alexa Fluor dyes, Cy dyes, and other standard fluorophores that researchers have optimized for countless applications can now be repurposed for nanoscale imaging without requiring new chemical synthesis or specialized probes.

[IMAGE: Graphic illustration showing common fluorescent dyes such as Alexa Fluor 488, Cy3, and Texas Red being excited by an electron beam, with arrows linking to a multicolor electron microscopy image of a cell.]

Earlier attempts at achieving molecular specificity in electron microscopy relied on custom-engineered lanthanide nanoparticles, which require significant chemistry expertise to produce and characterize. The new finding dramatically lowers the barrier to adoption, enabling labs to draw from existing dye libraries and established protocols.

This discovery could reshape the supply chain for nanoscale imaging. Dye manufacturers such as Thermo Fisher Scientific and Cytiva may see increased demand as researchers seek to repurpose existing product lines for electron microscopy applications. Meanwhile, companies specializing in custom nanoparticle probes may face new competition from standard fluorophore suppliers.

"The fact that we can use off-the-shelf fluorescent dyes is a game-changer," said Prigozhin, the senior author. "Labs don't need to develop new chemistry or purchase expensive specialized reagents. They can literally take the antibodies they already have, label them with the same dyes they use for confocal microscopy, and run them in an electron microscope."

The cathodoluminescence approach works by focusing an electron beam onto a thin sample section. As the beam scans across the tissue, it generates two signals simultaneously: backscattered electrons produce the high-resolution structural image, while photons emitted from excited fluorophores are collected by a sensitive detector. The resulting data can be reconstructed to show both the cellular ultrastructure and the locations of specific proteins at nanometer precision.

From Flat Sections to 3D Volumes: Paving the Way for Cryo-Electron Microscopy

The current implementation of multicolor electron microscopy produces flat, two-dimensional images from thin tissue sections. While already a powerful tool for cell biology, the team is now working to extend the technique into three dimensions.

Two main approaches are under development. The first involves stacking serial ultrathin sections—cutting a sample into a ribbon of nanometer-thick slices, imaging each one, and computationally reconstructing the 3D volume. This method has been used successfully in electron microscopy for decades but requires precise alignment and can introduce artifacts during sectioning.

The second, more ambitious approach adapts the technique for cryo-electron microscopy (cryo-EM), which rapidly freezes samples in their native, hydrated state without chemical fixation or staining. Cryo-EM preserves molecular structures at near-atomic resolution and is already revolutionizing structural biology.

[IMAGE: Conceptual illustration showing a vitrified sample being imaged in a cryo-electron microscope, with an electron beam generating both structural data and fluorescent signals from labeled proteins within the frozen sample.]

Adapting multicolor imaging to cryo-EM would allow researchers to visualize protein distributions within fully hydrated, vitrified cells—capturing molecular interactions in their most native state possible. This combination could unlock unprecedented views of cellular processes such as membrane trafficking, viral entry, and synaptic signaling.

"Three-dimensional cryo-electron microscopy with molecular specificity is the holy grail," explained Prigozhin. "If we can combine the structural power of cryo-EM with the molecular labeling capabilities we've demonstrated here, we could watch proteins interact in their natural environment at nanometer resolution."

The technical challenges are significant. Cathodoluminescence signals are generally weak, especially at cryogenic temperatures where fluorophore efficiency can change. The team is optimizing detector sensitivity and beam parameters to maximize signal while minimizing radiation damage to frozen samples.

Practical Applications: What This Means for Cell Biology, Pathology, and Drug Discovery

The immediate applications of multicolor electron microscopy span multiple fields. In cell biology, the technique enables researchers to map the precise locations of proteins within organelles, revealing how molecular machines are organized within cellular compartments. This level of spatial information is critical for understanding fundamental processes such as protein trafficking, signal transduction, and organelle dynamics.

[IMAGE: A multicolor electron microscopy image showing labeled mitochondria in green, endoplasmic reticulum in red, and nuclear pores in blue, overlaid on a gray-scale structural image of a mammalian cell.]

In pathology, the ability to visualize specific disease markers alongside cellular ultrastructure could transform how researchers study disease mechanisms. For example, scientists could examine how misfolded proteins aggregate in neurodegenerative diseases like Alzheimer's or Parkinson's, observing both the structural damage to neurons and the molecular composition of protein deposits simultaneously.

Drug discovery researchers could use the technique to visualize where therapeutic antibodies or small molecules bind within cells, providing crucial information about drug targeting and off-target effects. This could accelerate the development of more specific and safer therapeutics.

The Harvard team has already demonstrated the technique in mammalian cell cultures and in infected Drosophila (fruit fly) tissues, suggesting broad applicability across model organisms. The method's compatibility with standard sample preparation protocols means that existing tissue banks and clinical samples could potentially be re-examined with this new approach.

Industry Implications: A Potential Disruption in Microscopy Supply Chains

The discovery that standard fluorescent dyes work under electron beam excitation has significant implications for the microscopy supply chain. Currently, researchers seeking molecular specificity in electron microscopy must purchase specialized probes such as quantum dots, gold nanoparticles, or lanthanide-based cathodoluminescent materials. These reagents are expensive, often require custom synthesis, and have limited shelf lives.

The new approach could shift demand back toward conventional fluorophores, which are mass-produced at lower cost and benefit from decades of optimization. Dye manufacturers may need to certify their products for cathodoluminescence applications, while microscope manufacturers could develop dedicated cathodoluminescence detectors as standard accessories.

[IMAGE: Infographic showing the current supply chain for electron microscopy probes versus the proposed simplified pathway using standard fluorescent dyes and antibodies.]

Instrument companies like JEOL, Thermo Fisher Scientific (FEI), and Carl Zeiss may see opportunities to integrate cathodoluminescence detection systems into new microscope platforms. The technique requires modifications to existing electron microscopes, including specialized photon collection optics and sensitive detectors capable of capturing weak visible light signals.

For academic labs, the reduced reagent costs and simplified workflows could democratize access to high-resolution molecular imaging. Rather than requiring specialized nanoparticle expertise, any lab with standard antibody labeling capabilities and access to an electron microscope could potentially adopt the technique.

Looking Ahead: A New Chapter in Nanoscale Bioimaging

The presentation at the Biophysical Society Annual Meeting in February 2026 will mark the first public showcase of the technique's full capabilities. The Harvard team plans to release detailed protocols and validation data, enabling other laboratories to replicate and build upon their work.

Future directions include expanding the color palette—adding more spectrally distinct fluorophores to enable simultaneous visualization of multiple proteins—and developing software tools for automated analysis of multicolor electron microscopy data. The team is also exploring whether the technique can be extended to live-cell imaging, though the electron beam's damaging effects on living samples present substantial hurdles.

[IMAGE: A timeline graphic showing the evolution of microscopy techniques from light microscopy through electron microscopy to the new multicolor electron microscopy approach, highlighting resolution improvements and molecular specificity gains.]

The broader scientific community has responded with enthusiasm. Cell biologists see the technique as a way to connect molecular and structural scales that have traditionally been studied separately. Structural biologists appreciate the ability to add molecular context to atomic-resolution structures. And pathologists recognize the potential for diagnosing diseases based on both structural abnormalities and molecular markers in the same tissue sample.

"This isn't just an incremental improvement," said Roy. "It fundamentally changes what we can ask and answer about how cells work. When you can see both the forest and the trees—the cellular architecture and the individual proteins—you start to understand biology at a deeper level."

As the technique matures and becomes more widely available, it may well become a standard tool in bioimaging—joining the arsenal of methods that have expanded our view of the cellular world. For now, the Harvard breakthrough demonstrates that sometimes the most profound advances come not from inventing entirely new technologies, but from seeing old tools in a new light.